Hims & Hers vs Shed: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Shed beats Hims & Hers overall, scoring 8/10 vs 7.8/10. Shed is more affordable at $149/mo vs $199/mo. Choose Hims & Hers for users who want glp-1 access from a well-known, publicly trad. Choose Shed for users who want fast delivery and a streamlined compounded gl.
A side-by-side comparison of Hims & Hers and Shed covering pricing, scores, medication types, insurance, and more to help you decide.
Hims & Hers
#25 of 39One of the largest and most recognized telehealth platforms in the US, offering compounded GLP-1 medications with a polished user experience and strong brand trust.
Visit Hims & HersShed
#19 of 39Newer GLP-1 provider focused on speed and simplicity — fast approvals, fast shipping, and a clean user experience at a competitive price point.
Visit Shed| Feature | Hims & Hers | Shed |
|---|---|---|
| Our Score | 7.8/10 | 8/10 |
| Starting Price | $199/mo | $149/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want GLP-1 access from a well-known, publicly traded telehealth brand | Users who want fast delivery and a streamlined compounded GLP-1 experience |
| Ranking | #25 | #19 |
Pros & Cons Compared
Hims & Hers
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Polished app and web experience — one of the best user interfaces in telehealth
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Massive brand recognition means extensive customer support infrastructure and resources
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through their platform
- −Generic support experience — large patient volume means you're less likely to get personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
Shed
Pros
- +Industry-leading delivery speed — most patients receive medication within 2-3 days of enrollment
- +$149/mo is competitively priced for an all-inclusive compounded program with good support
- +Streamlined onboarding with no video call — approved and shipped faster than most competitors
- +Clean, modern UX with real-time shipping tracking and easy provider messaging
Cons
- −Compounded semaglutide and tirzepatide only — no brand-name options
- −Newer company (founded 2024) with limited track record and outcome data
- −No insurance billing and no FSA/HSA superbills currently available
- −Clinical support is responsive but less proactive than premium platforms
Our Verdict
Shed edges out Hims & Hers with a score of 8/10 vs 7.8/10. If budget is your priority, Shed starts at $149/mo compared to Hims & Hers's $199/mo. Choose Hims & Hers if you want: users who want glp-1 access from a well-known, publicly traded telehealth brand. Choose Shed if you want: users who want fast delivery and a streamlined compounded glp-1 experience.